Skip to main content
SpringerLink
Log in

Complement deficient mice as model systems for kidney diseases

  • Chapter
Book cover Complement and Kidney Disease

Part of the book series: Progress in Inflammation Research ((PIR))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kang HJ, Bao L, Xu Y, Quigg RJ, Giclas PC, Holers VM (2004) Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects. Clin Exp Immunol 136: 194–199

    Article  CAS  PubMed  Google Scholar 

  2. Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731–2738

    CAS  PubMed  Google Scholar 

  3. Couser WG (2003) Complement inhibitors and glomerulonephritis: are we there yet? J Am Soc Nephrol 14: 815–818

    PubMed  Google Scholar 

  4. Quigg RJ (1999) We need to inhibit complement in glomerular proteinuria. Kidney Int 56: 2314–2315

    Article  CAS  PubMed  Google Scholar 

  5. Quigg RJ, Lim A, Haas M, Alexander JJ, He C, Carroll MC (1998) Immune complex glomerulonephritis in C4-and C3-deficient mice. Kidney Int 53: 320–330

    Article  CAS  PubMed  Google Scholar 

  6. Sheerin NS, Springall T, Carroll MC, Hartley B, Sacks SH (1997) Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3-and C4-deficient mice. Clin Exp Immunol 110: 403–409

    Article  CAS  PubMed  Google Scholar 

  7. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH (2000) Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105: 1363–1371

    CAS  PubMed  Google Scholar 

  8. Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS (2004) Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int 65: 129–138

    Article  CAS  PubMed  Google Scholar 

  9. Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS (2000) Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 164: 786–794

    CAS  PubMed  Google Scholar 

  10. Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC (1995) Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA 92: 11490–11494

    CAS  PubMed  Google Scholar 

  11. Circolo A, Garnier G, Fukuda W, Wang X, Hidvegi T, Szalai AJ, Briles DE, Volanakis JE, Wetsel RA, Colten HR (1999) Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42: 135–149

    Article  CAS  PubMed  Google Scholar 

  12. Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL et al (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157: 549–556

    CAS  PubMed  Google Scholar 

  13. Botto M (1998) C1q knock-out mice for the study of complement deficiency in autoimmune disease. Exp Clin Immunogenet 15: 231–234

    Article  CAS  PubMed  Google Scholar 

  14. Matsumoto M, Fukuda W, Circolo A, Goellner J, Strauss-Schoenberger J, Wang X, Fujita S, Hidvegi T, Chaplin DD, Colten HR (1997) Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci USA 94: 8720–8725

    Article  CAS  PubMed  Google Scholar 

  15. Xu Y, Ma M, Ippolito GC, Schroeder HW Jr, Carroll MC, Volanakis JE (2001) Complement activation in factor D-deficient mice. Proc Natl Acad Sci USA 98: 14577–14582

    CAS  PubMed  Google Scholar 

  16. Shi L, Takahashi K, Dundee J, Shahroor-Karni S, Thiel S, Jensenius JC, Gad F, Hamblin MR, Sastry KN, Ezekowitz RA (2004) Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199: 1379–1390

    Article  CAS  PubMed  Google Scholar 

  17. Hopken UE, Lu B, Gerard NP, Gerard C (1996) The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383: 86–89

    CAS  PubMed  Google Scholar 

  18. Kildsgaard J, Hollmann TJ, Matthews KW, Bian K, Murad F, Wetsel RA (2000) Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective antiinflammatory role for C3a in endotoxin-shock. J Immunol 165: 5406–5409

    CAS  PubMed  Google Scholar 

  19. Orren A, Wallance ME, Horbart MJ, Lachmann PJ (1989) C6 polymorphism and C6 deficiency in site strains of the mutation-prone Peru-Coppock mice. Complement Inflamm 6: 295–296 (abstr)

    Google Scholar 

  20. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H (2000) A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287: 498–501

    Article  CAS  PubMed  Google Scholar 

  21. Lin F, Fukuoka Y, Spicer A, Ohta R, Okada N, Harris CL, Emancipator SN, Medof ME (2001) Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104: 215–225

    Article  CAS  PubMed  Google Scholar 

  22. Miwa T, Zhou L, Hilliard B, Molina H, Song WC (2002) Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99: 3707–3716

    Article  CAS  PubMed  Google Scholar 

  23. Holt DS, Botto M, Bygrave AE, Hanna SM, Walport MJ, Morgan BP (2001) Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98: 442–449

    Article  CAS  PubMed  Google Scholar 

  24. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31: 424–428

    CAS  PubMed  Google Scholar 

  25. Yamada K, Miwa T, Liu J, Nangaku M, Song WC (2004) Critical Protection from Renal Ischemia Reperfusion Injury by CD55 and CD59. J Immunol 172: 3869–3875

    CAS  PubMed  Google Scholar 

  26. Lin F, Emancipator SN, Salant DJ, Medof ME (2002) Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis. Lab Invest 82: 563–569

    Article  CAS  PubMed  Google Scholar 

  27. Sogabe H, Nangaku M, Ishibashi Y, Wada T, Fujita T, Sun X, Miwa T, Madaio MP, Song WC (2001) Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J Immunol 167: 2791–2797

    CAS  PubMed  Google Scholar 

  28. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA et al (2003) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112: 1644–1654

    Article  CAS  PubMed  Google Scholar 

  29. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM (2003) Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 170: 1517–1523

    CAS  PubMed  Google Scholar 

  30. Li B, Sallee C, Dehoff M, Foley S, Molina H, Holers VM (1993) Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol 151: 4295–4305

    CAS  PubMed  Google Scholar 

  31. Qin X, Miwa T, Aktas H, Gao M, Lee C, Qian YM, Morton CC, Shahsafaei A, Song WC, Halperin JA (2001) Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b. Mamm Genome 12: 582–589

    Article  CAS  PubMed  Google Scholar 

  32. Nomura A, Nishikawa K, Yuzawa Y, Okada H, Okada N, Morgan BP, Piddlesden SJ, Nadai M, Hasegawa T, Matsuo S (1995) Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest 96: 2348–2356

    CAS  PubMed  Google Scholar 

  33. Levy M, Halbwachs-Mecarelli L, Gubler MC, Kohout G, Bensenouci A, Niaudet P, Hauptmann G, Lesavre P (1986) H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int 30: 949–956

    CAS  PubMed  Google Scholar 

  34. Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M (1995) Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 95: 1054–1061

    CAS  PubMed  Google Scholar 

  35. Volanakis JE, Frank MM (eds) (1998) The Human Complement System in Health and Disease. New York: Marcel Dekker, Inc.

    Google Scholar 

  36. Manderson AP, Botto M, Walport MJ (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22: 431–456

    Article  CAS  PubMed  Google Scholar 

  37. Takahashi M, Tack BF, Nussenzweig V (1977) Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. J Exp Med 145: 86–100

    Article  CAS  PubMed  Google Scholar 

  38. Vivanco F, Munoz E, Vidarte L, Pastor C (1999) The covalent interaction of C3 with IgG immune complexes. Mol Immunol 36: 843–852

    Article  CAS  PubMed  Google Scholar 

  39. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76: 227–324

    CAS  PubMed  Google Scholar 

  40. Dragon-Durey MA, Quartier P, Fremeaux-Bacchi V, Blouin J, de Barace C, Prieur AM, Weiss L, Fridman WH (2001) Molecular basis of a selective C1s deficiency associated with early onset multiple autoimmune diseases. J Immunol 166: 7612–7616

    CAS  PubMed  Google Scholar 

  41. Rupert KL, Moulds JM, Yang Y, Arnett FC, Warren RW, Reveille JD, Myones BL, Blanchong CA, Yu CY (2002) The molecular basis of complete complement C4A and C4B deficiencies in a systemic lupus erythematosus patient with homozygous C4A and C4B mutant genes. J Immunol 169: 1570–1578

    CAS  PubMed  Google Scholar 

  42. Walport MJ, Lachmann PJ (1988) Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases. Arthritis Rheum 31: 153–158

    CAS  PubMed  Google Scholar 

  43. Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19: 56–59

    CAS  PubMed  Google Scholar 

  44. Mitchell DA, Pickering MC, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook HT, Botto M, Walport MJ (2002) C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 168: 2538–2543

    CAS  PubMed  Google Scholar 

  45. Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot EM, Goodnow CC, Carroll MC (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9: 721–731

    Article  CAS  PubMed  Google Scholar 

  46. Einav S, Pozdnyakova OO, Ma M, Carroll MC (2002) Complement C4 is protective for lupus disease independent of C3. J Immunol 168: 1036–1041

    CAS  PubMed  Google Scholar 

  47. Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS (2001) Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J Immunol 166: 6444–6451

    CAS  PubMed  Google Scholar 

  48. Bao L, Haas M, Boackle SA, Kraus DM, Cunningham PN, Park P, Alexander JJ, Anderson RK, Culhane K, Holers VM et al (2002) Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J Immunol 168: 3601–3607

    CAS  PubMed  Google Scholar 

  49. Bao L, Zhou J, Holers VM, Quigg RJ (2003) Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J Am Soc Nephrol 14: 2516–2525

    CAS  PubMed  Google Scholar 

  50. De Vries B, Matthijsen RA, Van Bijnen AA, Wolfs TG, Buurman WA (2003) Lysophosphatidic Acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol 163: 47–56

    PubMed  Google Scholar 

  51. De Vries B, Kohl J, Leclercq WK, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA (2003) Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170: 3883–3889

    PubMed  Google Scholar 

  52. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM (2003) A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 63: 134–142

    Article  CAS  PubMed  Google Scholar 

  53. Park P, Haas M, Cunningham PN, Alexander JJ, Bao L, Guthridge JM, Kraus DM, Holers VM, Quigg RJ (2001) Inhibiting the complement system does not reduce injury in renal ischemia reperfusion. J Am Soc Nephrol 12: 1383–1390

    CAS  PubMed  Google Scholar 

  54. Pratt JR, Jones ME, Dong J, Zhou W, Chowdhury P, Smith RA, Sacks SH (2003) Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol 163: 1457–1465

    CAS  PubMed  Google Scholar 

  55. Marsh JE, Farmer CK, Jurcevic S, Wang Y, Carroll MC, Sacks SH (2001) The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 72: 1310–1318

    CAS  PubMed  Google Scholar 

  56. Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8: 582–587

    Article  CAS  PubMed  Google Scholar 

  57. Pratt JR, Abe K, Miyazaki M, Zhou W, Sacks SH (2000) In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol 157: 825–831

    CAS  PubMed  Google Scholar 

  58. Trouw LA, Seelen MA, Daha MR (2003) Complement and renal disease. Mol Immunol 40: 125–134

    CAS  PubMed  Google Scholar 

  59. Quigg RJ (2003) Complement and the kidney. J Immunol 171: 3319–3324

    CAS  PubMed  Google Scholar 

  60. Quigg RJ, He C, Lim A, Berthiaume D, Alexander JJ, Kraus D, Holers VM (1998) Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med 188: 1321–1331

    Article  CAS  PubMed  Google Scholar 

  61. Holers VM, Thurman JM (2004) The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 41: 147–152

    Article  CAS  PubMed  Google Scholar 

  62. Sheerin NS, Springall T, Abe K, Sacks SH (2001) Protection and injury: the differing roles of complement in the development of glomerular injury. Eur J Immunol 31: 1255–1260

    Article  CAS  PubMed  Google Scholar 

  63. Muhlfeld AS, Segerer S, Hudkins K, Farr AG, Bao L, Kraus D, Holers VM, Quigg RJ, Alpers CE (2004) Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis. Kidney Int 65: 1214–1223

    Article  CAS  PubMed  Google Scholar 

  64. Couser WG (1985) Mechanisms of glomerular injury in immune-complex disease. Kidney Int 28: 569–583

    CAS  PubMed  Google Scholar 

  65. Huang XR, Holdsworth SR, Tipping PG (1997) Th2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 8: 1101–1108

    CAS  PubMed  Google Scholar 

  66. Robson MG, Cook HT, Botto M, Taylor PR, Busso N, Salvi R, Pusey CD, Walport MJ, Davies KA (2001) Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol 166: 6820–6828

    CAS  PubMed  Google Scholar 

  67. Sheerin NS, Sacks SH (2002) Leaked protein and interstitial damage in the kidney: is complement the missing link? Clin Exp Immunol 130: 1–3

    Article  CAS  PubMed  Google Scholar 

  68. Tang S, Lai KN, Chan TM, Lan HY, Ho SK, Sacks SH (2001) Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. Am J Kidney Dis 37: 94–103

    CAS  PubMed  Google Scholar 

  69. Tang S, Sheerin NS, Zhou W, Brown Z, Sacks SH (1999) Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. J Am Soc Nephrol 10: 69–76

    CAS  PubMed  Google Scholar 

  70. Nath KA, Hostetter MK, Hostetter TH (1985) Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 76: 667–675

    CAS  PubMed  Google Scholar 

  71. Rangan GK, Pippin JW, Couser WG (2004. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int 66: 1838–1848

    Article  CAS  PubMed  Google Scholar 

  72. Abbate M, Zoja C, Rottoli D, Corna D, Perico N, Bertani T, Remuzzi G (1999) Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein-and complement-dependent interstitial inflammation in experimental renal disease. J Am Soc Nephrol 10: 804–813

    CAS  PubMed  Google Scholar 

  73. Markiewski MM, Mastellos D, Tudoran R, DeAngelis RA, Strey CW, Franchini S, Wetsel RA, Erdei A, Lambris JD (2004) C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol 173: 747–754

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, B-115, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Denver, CO, 80262, USA

    Joshua M. Thurman & V. Michael Holers

Authors
  1. Joshua M. Thurman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Michael Holers
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Beutenbergstr. 11a, D-07745, Jena, Germany

    Peter F. Zipfel

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Thurman, J.M., Holers, V.M. (2006). Complement deficient mice as model systems for kidney diseases. In: Zipfel, P.F. (eds) Complement and Kidney Disease. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7428-4_4

Download citation

Publish with us

Policies and ethics

Search

Navigation